Bharat Biotech’s Covid vaccine 1st in India to get approval for human trials India's top drug regulator, Central Drugs Standard Control Organisation, has granted approval to Bharat Biotech India to conduct human clinical trials for ‘Covaxin’, making it the first Covid-19 vaccine candidate in India to receive this approval, the firm said on Monday. These trials are scheduled to start across India in July. The permission was granted after the company submitted results from pre-clinical studies of the vaccine that demonstrated its safety and immune response, said Bharat Biotech in its release. The vaccine was developed in collaboration with the National Institute of Virology. Hopefully a successful outcome in this regard would be a shot in the arm for the worldwide campaign against the coronavirus and inspire other efforts.